Filing Details
- Accession Number:
- 0001209191-22-057418
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-16 20:00:11
- Reporting Period:
- 2022-11-14
- Accepted Time:
- 2022-11-16 20:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1630627 | Treace Medical Concepts Inc. | TMCI | Surgical & Medical Instruments & Apparatus (3841) | 471052611 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856371 | F. Sean Scanlan | C/O Treace Medical Concepts, Inc. 100 Palmetto Park Place Ponte Vedra FL 32081 | Svp, Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-14 | 25,000 | $0.10 | 34,975 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-11-14 | 25,000 | $24.27 | 9,975 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-11-14 | 25,000 | $0.10 | 25,000 | $0.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 108,750 | 2018-12-15 | 2024-12-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Includes 9,975 RSUs.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from$23.8000 to $24.5500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of theSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within therange set forth in this footnote.
Billionaire Hedge Funds
